AAMU
INO icon

Amundi Asset Management US’s Inovio Pharmaceuticals INO Stock Holding History

Amundi Asset Management US’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,420
Closed -$576K – 1558
2020
Q4 		$576K Buy
5,420
+4,145
+325% +$552K ﹤0.01% 1273
2020
Q3 		$177K Sell
1,275
-50
-4% -$10.4K ﹤0.01% 1397
2020
Q2 		$429K Buy
+1,325
New +$213K ﹤0.01% 1270
2018
Q4 		– Sell
-1,883
Closed -$126K – 1632
2018
Q3 		$126K Buy
1,883
+966
+105% +$53.8K ﹤0.01% 1505
2018
Q2 		$43K Hold
917
– – ﹤0.01% 1520
2018
Q1 		$52K Buy
917
+109
+13% +$5.9K ﹤0.01% 1485
2017
Q4 		$40K Buy
+808
New +$50.1K ﹤0.01% 1521

Other funds holding INO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Asset Management US's INO Position: Q1 2021 in Review

Amundi Asset Management US sold out of Inovio Pharmaceuticals (INO) in Q1 2021, closing a stake of 5,420 shares — an estimated $576K sold.

Amundi Asset Management US first reported a position in INO in Q4 2017 and held it in 7 quarters. The position peaked at $576K in Q4 2020. 218 funds tracked by Wall St. Rank hold INO as of Q1 2021.

  • Amundi Asset Management US reported no remaining Inovio Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 5,420 Inovio Pharmaceuticals shares in Q1 2021, an estimated $576K.
  • Amundi Asset Management US first reported a position in Inovio Pharmaceuticals in Q4 2017 and held it in 7 quarters.
  • Amundi Asset Management US's Inovio Pharmaceuticals position peaked at $576K in Q4 2020.
  • 218 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.